Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Frost Phillip Md Et Al is CEO & Chairman at Opko Health. OQRO lists 62 transactions filed with the SEC under this name, the latest on Aug 6, 2026, each linked to the official Form 4.
CEO & Chairman
Disclosures on record
62
Companies involved
2
30 buys, median −2.2 pts vs S&P 500, beat it 13 of 30 times.
Average −0.2 pts vs S&P 500. Each buy is one disclosure of open-market purchases in one company on one filing date, filed Nov 14, 2024 to Aug 6, 2026, measured from the first close after the filing. Past results, not a forecast.
Cocrystal PharmaCOCP
12 disclosures · Nov 2025 – Aug 2026 · 11 bought
Aug 5, 2026Bought~$9.8Kdisclosed Aug 6
DetailsOfficial recordAug 3, 2026Bought~$71Kdisclosed Aug 5
DetailsFeb 24, 2026Bought~$20Kdisclosed Feb 25
DetailsOfficial recordFeb 6, 2026Bought~$47Kdisclosed Feb 9
DetailsOfficial recordJan 9, 202625Kdisclosed Jan 13
DetailsOfficial recordDec 31, 2025Bought~$47Kdisclosed Jan 2
DetailsOfficial recordDec 30, 2025Bought~$19Kdisclosed Dec 31
DetailsOfficial recordDec 26, 2025Bought~$39Kdisclosed Dec 29
DetailsOfficial recordDec 24, 2025Bought~$24Kdisclosed Dec 29
DetailsOfficial recordNov 26, 2025Bought~$1.5Kdisclosed Nov 28
DetailsOfficial recordNov 26, 2025Bought~$2.5Kdisclosed Nov 28
DetailsOfficial recordNov 25, 2025Bought~$19Kdisclosed Nov 26
DetailsOfficial recordOpko HealthOPK
50 disclosures · Nov 2024 – Nov 2025 · 49 bought
Nov 21, 2025Bought~$257K
DetailsOfficial recordNov 21, 2025Bought~$255K
DetailsOfficial recordNov 21, 2025Bought~$133K
DetailsOfficial recordNov 21, 2025Bought~$118K
DetailsOfficial recordNov 21, 2025Bought~$5.1K
DetailsOfficial recordNov 20, 2025Bought~$282K
DetailsOfficial recordNov 20, 2025Bought~$216K
DetailsOfficial recordNov 20, 2025Bought~$157K
DetailsOfficial recordNov 20, 2025Bought~$62K
DetailsOfficial recordNov 20, 2025Bought~$33K
DetailsOfficial recordNov 20, 2025Bought~$18K
DetailsOfficial recordNov 20, 2025Bought~$2.4K
DetailsOfficial recordNov 19, 2025Bought~$262K
DetailsOfficial recordNov 19, 2025Bought~$205K
DetailsOfficial recordNov 19, 2025Bought~$87K
DetailsOfficial recordNov 19, 2025Bought~$75K
DetailsOfficial recordNov 19, 2025Bought~$46K
DetailsOfficial recordNov 19, 2025Bought~$39K
DetailsOfficial recordNov 19, 2025Bought~$28K
DetailsOfficial recordNov 19, 2025Bought~$17K
DetailsOfficial recordNov 19, 2025Bought~$387
DetailsOfficial recordNov 18, 2025Bought~$271K
DetailsOfficial recordNov 18, 2025Bought~$107K
DetailsOfficial recordNov 18, 2025Bought~$89K
DetailsOfficial recordNov 18, 2025Bought~$84K
DetailsOfficial recordNov 18, 2025Bought~$62K
DetailsOfficial recordNov 18, 2025Bought~$43K
DetailsOfficial recordNov 18, 2025Bought~$19K
DetailsOfficial recordNov 18, 2025Bought~$510
DetailsOfficial recordNov 18, 2025Bought~$2.3K
DetailsOfficial recordNov 18, 2025Bought~$550
DetailsOfficial recordNov 18, 2025Bought~$1
DetailsOfficial recordNov 18, 202547K
DetailsOfficial recordOct 31, 2025Bought~$213K
DetailsOfficial recordAug 8, 2025Bought~$891K
DetailsOfficial recordApr 10, 2025Bought~$170K
DetailsOfficial recordApr 8, 2025Bought~$185K
DetailsOfficial recordApr 1, 2025Bought~$165K
DetailsOfficial recordMar 28, 2025Bought~$254K
DetailsOfficial recordMar 17, 2025Bought~$348K
DetailsOfficial recordFeb 28, 2025Bought~$115Kdisclosed Mar 1
DetailsOfficial recordJan 28, 2025Bought~$70K
DetailsOfficial recordJan 17, 2025Bought~$220K
DetailsOfficial recordJan 15, 2025Bought~$741K
DetailsOfficial recordDec 13, 2024Bought~$199K
DetailsOfficial recordDec 11, 2024Bought~$781K
DetailsOfficial recordNov 29, 2024Bought~$305K
DetailsOfficial recordNov 22, 2024Bought~$159K
DetailsOfficial recordNov 8, 2024Bought~$422Kdisclosed Nov 21
DetailsOfficial recordNov 14, 2024Bought~$162K
DetailsOfficial recordAs of the latest filing on , Frost Phillip Md Et Al reported holding 216,706,448 shares of Opko Health (OPK), worth about $351M at the last close of $2 (Nov 16, 2026), held through a see footnote. Holdings are also on file at Cocrystal Pharma (COCP); together they are worth about $353M. In the last 12 months, Frost Phillip Md Et Al bought $3.28M in 43 open-market purchases.
Opko Health's proxy statement reports total compensation of $1.85M for Frost Phillip Md Et Al for fiscal year 2025, after $2.16M for 2024. The total is the one in the Summary Compensation Table: it counts stock awards at their value on the grant date, so it is not the cash received. Proxy statement filed Apr 30, 2026
| Company | Shares reported | How held | Last close | Value at last close | Reported |
|---|---|---|---|---|---|
| Opko Health OPK | 216,706,448 | 216.7M see footnote | $2 | $351M | Nov 21, 2025 |
| Cocrystal Pharma COCP | 1,993,551 | 1.99M frost gamma investments trust | $1 | $1.95M | Aug 5, 2026 |
Is this Frost Phillip Md Et Al’s net worth? No. A Form 4 reports the shares an insider owns in one company after each transaction, directly or through trusts and entities. It says nothing about cash, other investments, property or debt, options not yet exercised are not counted here, and a holding reported some time ago may have changed without a new filing. The value is shares times the last stored close, not a price anyone received. Sources: the filings listed below, each linked to EDGAR. Compare with the biggest insider stakes.
Frost Phillip Md Et Al bought shares on the open market in 20 different years since 2007 across 8 companies. Sales in 2 of the 20 years since 2007.
Frost Phillip Md Et Al reported 6,386 open-market purchases and 140 sales since 2007; purchases in 20 different years, most recently 2026.
| Year | Bought | Sold |
|---|---|---|
| 2026 | $148K4×4 trades | — |
| 2025 | $6.5M50×50 trades | — |
| 2024 | $4.35M10×10 trades | $56K1×1 trade |
| 2023 | $4.95M52×52 trades | — |
| 2022 | $8.44M187×187 trades | — |
| 2021 | $2.56M49×49 trades | — |
| 2020 | $7.13M74×74 trades | — |
| 2019 | $9.28M195×195 trades | — |
| 2018 | $7.02M301×301 trades | — |
| 2017 | $19.2M461×461 trades | — |
| 2016 | $22.6M643×643 trades | — |
| 2015 | $17.9M622×622 trades | — |
| 2014 | $31.5M1176×1,176 trades | — |
| 2013 | $21.5M707×707 trades | — |
| 2012 | $29.1M757×757 trades | — |
| 2011 | $17.8M385×385 trades | — |
| 2010 | $1.51M261×261 trades | — |
| 2009 | $2.76M222×222 trades | $4.32M139×139 trades |
| 2008 | $15.5M154×154 trades | — |
| 2007 | $7.77M76×76 trades | — |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. Dollar totals use the price the filer reported; lines with no price count as trades without a value.
On the latest SEC Form 4, dated Nov 21, 2025, Frost Phillip Md Et Al reported holding 216,706,448 shares of Opko Health (OPK), held indirectly. At the last close of $2 on Nov 16, 2026, that is about $351M. This is the stake disclosed in filings, not a net worth.
In SEC filings of the last 12 months, Frost Phillip Md Et Al reported 43 open-market purchases worth $3.28M, and no open-market sale. Shares withheld for taxes, gifts and option exercises are not counted in these totals.
Opko Health's proxy statement reports total compensation of $1.85M for Frost Phillip Md Et Al for fiscal year 2025, after $2.16M for 2024. The total is the one in the Summary Compensation Table: it counts stock awards at their value on the grant date, so it is not the cash received.
Frost Phillip Md Et Al bought shares on the open market in 20 different years since 2007 across 8 companies. Sales in 2 of the 20 years since 2007.
In SEC filings since 2007: the latest open-market purchase is from 2026; the latest open-market sale is from 2024.
8 companies: Cocrystal Pharma (COCP, 2016–2026), Opko Health (OPK, 2007–2025), Biocardia (BCDA, 2009–2024), Fluent (FLNT, 2010–2023), Eloxx Pharmaceuticals (ELOX, 2015) and others.
Frost Phillip Md Et Al reported 6,338 open-market purchases and 0 sales here, 2007 to 2025.
Frost Phillip Md Et Al reported 0 open-market purchases and 139 sales here, 2009.
Frost Phillip Md Et Al reported 18 open-market purchases and 1 sale here, 2009 to 2024.
Closing prices and the companies' last annual figures; a − or + is a fact of the close, not a forecast.